This clinical research study is for adults aged 18 to 44 who are currently experiencing facial acne. The study will evaluate the safety and potential effects of a new investigational acne treatment.
What to Expect
Participants will be randomly assigned to receive either the investigational acne treatment or a placebo. Neither participants nor study staff will know which treatment is assigned during the study.
All study-related care will be provided at no cost, and eligible participants may receive compensation for their time and travel.
Trial Requirements
- Adults 18–44 years old
- Currently experiencing mild to sever acne
- Willing to follow study visit schedule
- Additional criteria may apply
Urgently Recruiting
Trial Details
This study aims to assess the safety, tolerability, and potential skin-clearing benefit of a new investigational acne treatment. The goal is to learn more about how this product may help reduce breakouts and improve quality of life for individuals affected by acne.
Participants will undergo regular health assessments, including skin evaluations and digital photography, to track treatment outcomes over time.
